Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Classical hematology 1Breast 1

Conditions

Breast Neoplasms 23Venous Thromboembolism 1Unilateral Breast Neoplasms 1Triple Negative Breast Neoplasms 1Sarcoma 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms by Site 1Neoplasms 1Neoplasm Metastasis 1Meningioma 1Melanoma 1Liposarcoma 1Leiomyosarcoma 1HR+HER2- Advanced Breast Cancer 1Glioblastoma 1Endometrial Neoplasms 1EGFR-mutant Non-small Cell Lung Cancer 1Cystadenocarcinoma, Serous 1Continued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies 1Colorectal Neoplasms 1Cardiovascular Diseases 1Carcinoma, Non-Small-Cell Lung 1Breast Diseases 1Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

ribociclib 1palbociclib 1edoxaban 1apixaban 1abemaciclib 1Rivaroxaban 1Heparin, Low-Molecular-Weight 1Dabigatran 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Venous Thromboembolism × ribociclib × Clear all
NCT07008508 2025-06-06

BRAVE-Cyclin

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Active not recruiting
300 enrolled
BreastClassical hematology

Breast Neoplasms, Cardiovascular Diseases, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡